IP Library › Granted Patent US 10,137,178
Granted Patent B2
US 10,137,178 · App. 15/312,431 · Granted Nov 27, 2018

Dental gel composition of papain for the atraumatic treatment of caries and method of preparing same

Inventor: Mauricio Dobboletta (Santa Fe, AR)
Assignee: BRIX USA, LLC
A61K38/4873A61C5/62A61C19/063A61K8/042A61K8/11A61K8/24A61K8/345A61K8/37A61K8/41A61K8/49A61K8/66A61K8/86A61K9/06A61K47/02A61K47/10A61K47/14A61K47/18A61K47/22A61K47/26A61K47/36A61Q11/00C12Y304/22002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,137,178
App. No.
15/312,431
Granted
Nov 27, 2018
Kind
B2
Abstract

A papain dental gel composition is disclosed for the atraumatic treatment of caries which comprises papain with a final activity of at least 3,000 U/mg, wherein the papain is bio-encapsulated in a mixture of pH=7 buffer-C 3-6 polyol-pectin-C 2-6 alkanolamine-nonionic emulsifier, together with pharmaceutically acceptable coloring agents, preservatives and solvents. A method of preparing said papain composition is also disclosed.

Claims (43)

1. A dental composition of papain in the form of a gel for the atraumatic treatment of caries comprising papain with a final activity of at least 3,000 U/mg, wherein the papain is bio-encapsulated in a mixture comprising all of the following ingredients:

pH=7 buffer,

a C 3-6 polyol,

pectin,

C 2 - 6 alkanolamine,

a nonionic emulsifier,

optionally a pharmaceutically acceptable coloring agent

a preservative, and

a solvent,

wherein the composition does not include chloramine.

2. The composition according to claim 1 , wherein the pH=7 buffer is selected from the group consisting of: disodium or dipotassium acid phosphate (Na 2 HPO 4 , K 2 HPO 4 )/citric acid (C 6 H 8 O 7 ), sodium chloride (NaCI)/ sodium citrate (C 6 H 5 O 7 Na 3 . 2H 2 O)/sodium hydroxide (NaOH), sodium or potassium diacid phosphate (NaH 2 PO 4 , KH 2 PO 4 )/disodium or dipotassium acid phosphate (Na 2 HPO 4 , K 2 HPO 4 ), tris-(hydroxymethyl)-aminomethane (TRIS)/hydrochloric acid (HCI).

3. The composition according to claim 1 , wherein the pH=7 buffer is KH 2 PO4/Na 2 HPO 4 .

4. The composition according to claim 1 , wherein the C 3 - 6 polyol is selected from the group consisting of: 1,2,3-propanetriol (glycerin), 1,2-propanediol (propyleneglycol), 1,3-butanediol, 1,4-butanediol, 1,3-butenediol, 2,3-butenediol, 2,2-dimethyl-1,3 propanediol (neopentylglycol), erythritol, sorbitol, mannitol, and mixtures thereof.

5. The composition according to claim 4 , wherein the C 3-6 polyol is 1,2-propanediol (propyleneglycol).

6. The composition according to claim 1 , wherein the pectin is apple bagasse pectin or citrus pectin.

7. The composition according to claim 6 , wherein the pectin employed is citrus pectin.

8. The composition according to claim 1 , wherein the C 2-6 alkanolamine is selected from the group consisting of: monoethanolamine, diethanolamine, triethanolamine and mixtures thereof.

9. The composition according to claim 8 , wherein the C 2-6 alkanolamine is triethanolamine.

10. The composition according to claim 1 , wherein the non-ionic emulsifier is selected from the group consisting of: polyoxyethylene stearate 8; polyoxyethylene stearate 40; polyoxyethylene sorbitan monolaurate 20; polyoxyethylene sorbitan monooleate 20; polyoxyethylene sorbitan monopalmitate 20; polyoxyethylene sorbitan monostearate 20; polyoxyethylene sorbitan tristearate 20; and mixtures thereof.

11. The corn position according to claim 10 , wherein the non-ionic emulsifier is polyoxyethylene sorbitan monooleate 20.

12. The composition according to claim 1 , wherein the pharmaceutically acceptable coloring agent is present and is selected from the group consisting of: methyl blue, toluidine blue, methyl green, methylene green, gentian violet, malachite green, methylene yellow, and mixtures thereof.

13. The composition according to claim 12 , wherein the pharmaceutically acceptable coloring agent is toluidine blue.

14. The composition according to claim 12 , wherein the preservative is selected from the group consisting of: methylparaben, ethylparaben, propylparaben and mixtures thereof.

15. The composition according to claim 14 , wherein the preservative is the mixture of methylparaben and propylparaben.

16. A dental composition of papain in the form of a gel for the atraumatic treatment of caries, said composition comprising papain 10.00% w/w, citrus pectin 8.00% w/w, propyleneglycol 8.00% w/w, triethanolamine 0.72% w/w, polyoxyethylene-20 sorbitan monooleate 0.50% w/w, KH 2 PO 4 0.0378% w/w, Na 2 HPO 4 0.1283%, toluidine blue (1% w/w aq. sol.) 0.09% w/w, methylparaben 0.10% w/w, propylparaben 0.05% w/w, and distilled water 72.37% w/w,

wherein the composition has a final activity of papain of at least 3000 U/mq, and

wherein the composition does not include chloramine.

17. A method of preparing the papain dental composition of claim 1 for the atraumatic treatment of caries, said method comprising:

a) adding to distilled water while stirring at approximately 1,500 rpm the components of a pH=7 buffer, one or more pharmaceutically acceptable preservatives, and finally 30,000 U/mg papain until complete dispersion to a final neutral pH (pH=7);

b) wetting pectin while stirring in a C 3-6 polyol, then adding the non-ionic emulsifier, and finally a C 2-6 alkanolamine until neutralization of the pectin acidity thus forming a neutral encapsulating emulsion (pH=7); and

c) adding the neutral encapsulating emulsion from step b) to the dispersion obtained in step a) under low speed stirring to obtain a stable gel comprising papain.

18. The method according to claim 17 , said method comprising a further step of adding under stirring, to the stable gel comprising papain, a coloring agent dissolved in a pharmaceutically acceptable solvent.

19. The method according to claim 17 , wherein the stirring in step c) is performed at between approximately 20 and approximately 150 rpm.

20. The method according to claim 17 , wherein the concentration ratio of pectin/C 3-6 polyol/C 2-6 alkanolamine employed ranges from 4/4/0.36 to 10/10/0.90 expressed in % w/w, respectively.

21. The method according to claim 20 , wherein the concentration ratio of pectin/C 3-6 polyol/C 2-6 alkanolamine is 8/8/0.72 expressed in % w/w.

22. The method according to claim 17 , said method further comprising the step of packing the obtained gel into multi-dose syringes.

23. A method of preparing the papain dental composition of claim 1 for the atraumatic treatment of caries, said method comprising:

a) adding to distilled water while stirring at approximately 1,500 rpm potassium monobasic phosphate, sodium diacid phosphate, methylparaben, propylparaben, and finally 30,000 U/mg papain until complete dispersion to a final neutral pH (pH=7);

b) wetting while stirring citrus pectin in propyleneglycol, adding polyoxyethylene sorbitan monooleate 20 , and finally triethanolamine until neutralization of the citrus pectin thus forming a neutral encapsulating emulsion (pH=7), wherein the concentration ratio of citrus pectin/propyleneglycol/triethanolamine employed ranges from 4/4/0.36 to 10/10/0.90 expressed in % w/w, respectively;

c) adding the neutral encapsulating emulsion from step b) to the dispersion obtained in step a) under low speed stirring between approximately 20 and approximately 150 rpm to obtain a stable gel of papain dispersion;

d) adding under stirring to the stable gel of papain toluidine blue as coloring agent dissolved in a pharmaceutically acceptable solvent; and

e) packing the obtained gel into multi-dose syringes.

24. The method according to claim 23 , wherein the toluidine blue coloring agent is added as a solution of 1% w/w toluidine blue dissolved in distilled water.

Priority Claims (1)
AR P20140101998 · May 20, 2014 · national
Continuity (1)
Related Publication 20170100464A1 · Apr 13, 2017